RLT-Connect

Online platform connecting healthcare professionals and RadioLigand Therapy providers to enable treatment access for cancer patients, worldwide.

Available in several pilot countries, full-scale deployment in March 2024.

In establishing ‘RLT-Connect,’ Oncidium foundation has forged a comprehensive ecosystem—a true chain of solidarity extending from therapy centers to radiopharmacies, and Radioisotope suppliers—all united in pursuit of a common mission to ensure that every cancer patient has an equal opportunity to access a potentially life-saving technology, whoever and wherever they are.

Rebecca Lo bue, General manager of the Oncidium foundation

Read the Press Release >>

THE UNMET NEED: INEQUALITIES IN TREATMENT ACCESS

Access to radioligand therapies is deeply unequal around the world:

  • Technology available only to a small number of cancer patients
  • Access is dependent on where the patient lives
  • In most low-and middle-income new radiopharmaceuticals are paid out-of-pocket

Connections are really low and sometimes inexistent.

TAKE ACTION: GET INVOLVED TODAY

Help to save lives and…

  • Improve access to medicines
  • Demonstrate ESG commitment
  • Generate real-world evidence (RWE)
  • Contribute to the development of the field

GET EARLY ACCESS!

Share your email and be the first to know when RLT-Connect launches in early 2024.

How can I help?

It’s all about connections

The RLT-Connect platform is an online platform designed to facilitate collaboration between healthcare professionals seeking radioligand therapy for their patients who cannot afford it, and Radioisotope suppliers willing to donate doses to make this life-saving treatment accessible to those in need

OUR GENEROUS SUPPORTERS

How can we aim higher?

  • Structure and broaden access
  • Ease connections within Radiotheranostics ecosystem
  • Save lives by giving access to therapy despite inequalities

Contact us for questions or if you want more information.